Investigational Drug Information for BMS-986205
✉ Email this page to a colleague
What is the drug development status for BMS-986205?
BMS-986205 is an investigational drug.
There have been 23 clinical trials for BMS-986205.
The most recent clinical trial was a Phase 3 trial, which was initiated on November 30th 2017.
The most common disease conditions in clinical trials are Carcinoma, Non-Small-Cell Lung, Urinary Bladder Neoplasms, and Melanoma. The leading clinical trial sponsors are Bristol-Myers Squibb, National Cancer Institute (NCI), and Clovis Oncology, Inc.
There are two US patents protecting this investigational drug and thirty-seven international patents.
Summary for BMS-986205
| US Patents | 2 |
| International Patents | 37 |
| US Patent Applications | 27 |
| WIPO Patent Applications | 16 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 3 (2017-11-30) |
| Vendors | 37 |
Recent Clinical Trials for BMS-986205
| Title | Sponsor | Phase |
|---|---|---|
| Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment | Bristol-Myers Squibb | Phase 2 |
| Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment | Memorial Sloan Kettering Cancer Center | Phase 2 |
| A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma | Bristol-Myers Squibb | Phase 2 |
Clinical Trial Summary for BMS-986205
Top disease conditions for BMS-986205
Top clinical trial sponsors for BMS-986205
US Patents for BMS-986205
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| BMS-986205 | ⤷ Sign Up | Immunoregulatory agents | Flexus Biosciences, Inc. (Princeton, NJ) | ⤷ Sign Up |
| BMS-986205 | ⤷ Sign Up | Immunoregulatory agents | FLEXUS BIOSCIENCES, INC. (Princeton, NJ) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for BMS-986205
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| BMS-986205 | Argentina | AR102536 | 2034-11-05 | ⤷ Sign Up |
| BMS-986205 | Australia | AU2015342940 | 2034-11-05 | ⤷ Sign Up |
| BMS-986205 | Brazil | BR112017008568 | 2034-11-05 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
